Quotient Wealth Partners LLC lifted its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 22.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,057 shares of the company’s stock after purchasing an additional 192 shares during the quarter. Quotient Wealth Partners LLC’s holdings in HCA Healthcare were worth $405,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of HCA. Cheviot Value Management LLC purchased a new stake in HCA Healthcare during the 1st quarter valued at about $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare during the 1st quarter valued at about $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare during the 1st quarter valued at about $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. The Goldman Sachs Group assumed coverage on HCA Healthcare in a report on Tuesday. They issued a “buy” rating and a $470.00 price objective for the company. Bank of America increased their price objective on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Cantor Fitzgerald reissued an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 7th. UBS Group increased their target price on HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a research report on Tuesday. Finally, Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $434.00.
Insider Buying and Selling
In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.
HCA Healthcare Stock Up 1.4%
HCA stock opened at $425.50 on Friday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $439.01. The firm has a market cap of $99.56 billion, a PE ratio of 17.89, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. The business has a 50 day moving average of $410.05 and a 200 day moving average of $378.42.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the company earned $5.50 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- What is a Secondary Public Offering? What Investors Need to Know
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- Why Are Stock Sectors Important to Successful Investing?
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- What is Put Option Volume?
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.